Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 May-Jun;32(3-4):195-200.
doi: 10.1016/j.jaut.2009.02.021. Epub 2009 Apr 1.

B cells contribute to ischemia/reperfusion-mediated tissue injury

Affiliations

B cells contribute to ischemia/reperfusion-mediated tissue injury

Jie Chen et al. J Autoimmun. 2009 May-Jun.

Abstract

Multiple elements are known to participate in ischemia/reperfusion (I/R)-mediated tissue injury. Amongst them, B cells have been shown to contribute by the production of antibodies that bind to ischemic cells and fix complement. It is currently unknown whether B cells participate through antibody-independent mechanisms in the pathogenesis of I/R. In a mesenteric I/R model we found that B cells infiltrate the injured intestine of normal and autoimmune mice 2h after reperfusion is established. B cell depletion protected mice from the development of I/R-mediated intestinal damage. The protection conferred by B cell depletion was significantly greater in MRL/lpr mice. Finally, we show that ischemic tissue expressed the B cell-attractant CXCL13 and infiltrating B cells expressed the corresponding receptor CXCR5. Our data grant B cells an antibody-independent role in the pathogenesis of intestinal I/R and suggest that B cells accumulate in the injured tissue in response to the chemokine CXCL13.

PubMed Disclaimer

Figures

Figure 1
Figure 1. B cells infiltrate ischemic intestine during reperfusion
A. C57Bl/6 mice were subjected to sham procedure or I/R. Immunohistochemistry was performed with an anti-B220 antibody. Magnification 200×. B. B cell infiltration was quantified with image analysis software. *p<0.001 when compared to sham mice.
Figure 2
Figure 2. I/R leads to an increase in the number of B cells within Payer’s patches
A. The number of B220+ cells in Payer’s patches increases following I/R (magnification 200×). B. Payer’s patches were isolated and cells were stained with anti-B220 antibody. B cells were quantified in a flow cytometer. C. Cumulative data of flow cytometry experiments (n=7 per group). *p<0.001 when compared to Sham.
Figure 3
Figure 3. MRL/lpr mice are resistant to complete B cell depletion
A depleting anti-mouse CD20 antibody was administered in a single dose to mice 9 days before I/R was induced. C57Bl/6 mice received 20 µg per mice; MRL/lpr received 250 µg per mice. Cellular suspensions from blood and spleen were stained with anti-B220 and analyzed by flow cytometry.
Figure 4
Figure 4. B cell depletion reduces I/R-induced intestinal tissue injury
A. Tissue injury score was significantly reduced in C57Bl/6 (left panel) and MRL/lpr (right panel) mice depleted of B cells (black bars) when compared to B cell-sufficient mice (white bars). * p<0.01. B. The reduction in tissue injury scores was significantly greater in MRL/lpr mice than in control mice. * p<0.05.
Figure 5
Figure 5. CXCL13 expressed by injured tissue recruits CXCR5+ cells
Anti-CXCL13 (A) and anti-CXCR5 (B) antibodies were used to stain frozen sections from C57Bl/6 and MRL/lpr mice subjected to I/R (left panels) or sham (right panel) procedures (n=5). Magnification 200×. C. Total RNA was extracted from intestinal tissue of mice that had undergone I/R or sham (Sh) procedures. CXCL13 and CXCR5 transcripts were amplified by reverse transcriptase-PCR.
Figure 6
Figure 6. CXCR5 expression is limited to B cells
Intestinal sections C57Bl/6 mice subjected to I/R were stained with FITC-labeled anti-B220 and PE-labeled anti-CXCR5 antibody and scanned in a confocal microscope.

Similar articles

Cited by

References

    1. Fleming SD, Tsokos GC. Complement, natural antibodies, autoantibodies and tissue injury. Autoimmun Rev. 2006;5:89–92. - PubMed
    1. Huang Y, Rabb H, Womer KL. Ischemia-reperfusion and immediate T cell responses. Cell Immunol. 2007;248:4–11. - PMC - PubMed
    1. Edgerton C, et al. IL-17 producing CD4+ T cells mediate accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice. Clin Immunol. 2008 in press. - PMC - PubMed
    1. Tsokos GC. B cells, be gone--B-cell depletion in the treatment of rheumatoid arthritis. N Engl J Med. 2004;350:2546–2548. - PubMed
    1. Burne MJ, et al. Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest. 2001;108:1283–1290. - PMC - PubMed

Publication types

MeSH terms